111 related articles for article (PubMed ID: 26957307)
1. GMP-grade α-TEA lysine salt: a 28-Day oral toxicity and toxicokinetic study with a 28-Day recovery period in Beagle dogs.
Guerrouahen BS; Hahn T; Alderman Z; Curti B; Urba W; Akporiaye ET
BMC Cancer; 2016 Mar; 16():199. PubMed ID: 26957307
[TBL] [Abstract][Full Text] [Related]
2. Repeat dose study of the novel proapoptotic chemotherapeutic agent alpha-tocopheryloxy acetic acid in mice.
Hahn T; Akporiaye ET
Anticancer Drugs; 2012 Apr; 23(4):455-64. PubMed ID: 22185820
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
4. A safety study of a novel photosensitizer, sinoporphyrin sodium, for photodynamic therapy in Beagle dogs.
Lin N; Li C; Wang Z; Zhang J; Ye X; Gao W; Wang A; Jin H; Wei J
Photochem Photobiol Sci; 2015 Apr; 14(4):815-32. PubMed ID: 25671327
[TBL] [Abstract][Full Text] [Related]
5. Subchronic toxicity and toxicokinetics of MCC-555, a novel thiazolidinedione, after 270-day repeated oral administration in dogs.
Sun N; Lu G; Lin M; Fan G; Wu Y
Environ Toxicol Pharmacol; 2009 Mar; 27(2):237-46. PubMed ID: 21783946
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: a 26-week intramuscular repeated administration study in Beagle dogs.
Liu JP; Lu D; Nicholson RC; Li PY; Wang F
Food Chem Toxicol; 2011 Aug; 49(8):1718-27. PubMed ID: 21540070
[TBL] [Abstract][Full Text] [Related]
7. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.
Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK
Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009
[TBL] [Abstract][Full Text] [Related]
8. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
[TBL] [Abstract][Full Text] [Related]
9. Acute, subacute and chronic oral toxicity studies of the new serotonin (5-HT)3-receptor antagonist ramosetron in beagle dogs.
Tabata H; Matsuzawa T; Hanada T; Ishikawa A; Yamada M; Ozaki H; Izumisawa N; Barker MH; Cox RA; Buist DP
Arzneimittelforschung; 1995 Jul; 45(7):760-6. PubMed ID: 8573218
[TBL] [Abstract][Full Text] [Related]
10. Safety and pharmacokinetic studies of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol or γ-tocopherol in beagle dogs.
Alipour M; Mitsopoulos P; Smith MG; Bolger G; Pucaj K; Suntres ZE
Toxicol Mech Methods; 2013 Jul; 23(6):419-31. PubMed ID: 23384394
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
12. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
Han J; Shin HC; Kim JC; Kim B
Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
[TBL] [Abstract][Full Text] [Related]
13. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
[TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics of naringin and its metabolite naringenin after 180-day repeated oral administration in beagle dogs assayed by a rapid resolution liquid chromatography/tandem mass spectrometric method.
Yang CP; Liu MH; Zou W; Guan XL; Lai L; Su WW
J Asian Nat Prod Res; 2012; 14(1):68-75. PubMed ID: 22263596
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
16. Safety assessment of metarrestin in dogs: A clinical candidate targeting a subnuclear structure unique to metastatic cancer cells.
Bourdi M; Rudloff U; Patnaik S; Marugan J; Terse PS
Regul Toxicol Pharmacol; 2020 Oct; 116():104716. PubMed ID: 32619635
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
18. Twenty-eight days repeated oral dose toxicity study of gemifloxacin in Wistar albino rats.
Roy B; Sarkar AK; Sengupta P; Dey G; Das A; Pal TK
Regul Toxicol Pharmacol; 2010 Nov; 58(2):196-207. PubMed ID: 20580917
[TBL] [Abstract][Full Text] [Related]
19. Subchronic oral toxicity of ubiquinol in rats and dogs.
Kitano M; Watanabe D; Oda S; Kubo H; Kishida H; Fujii K; Kitahara M; Hosoe K
Int J Toxicol; 2008; 27(2):189-215. PubMed ID: 18404543
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of chronic toxicity of cyclocreatine in beagle dogs after oral gavage administration for up to 23 weeks.
Wallery JJ; Kale VP; Novak J; Gibbs S; Do MT; McKew JC; Terse PS
Toxicol Appl Pharmacol; 2021 Nov; 430():115680. PubMed ID: 34411581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
